pifithrin has been researched along with sirolimus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, X; Gu, S; Li, X; Ling, Y; Shen, C; Xie, R | 1 |
| Fu, W; Liu, Y; Sun, C; Yin, H | 1 |
2 other study(ies) available for pifithrin and sirolimus
| Article | Year |
|---|---|
p53 inhibition provides a pivotal protective effect against ischemia-reperfusion injury in vitro via mTOR signaling.
Topics: Animals; Benzothiazoles; Cells, Cultured; Female; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Pregnancy; Reperfusion Injury; Signal Transduction; Sirolimus; Toluene; TOR Serine-Threonine Kinases; Tumor Suppressor Protein p53 | 2015 |
Transient p53 inhibition sensitizes aged white adipose tissue for beige adipocyte recruitment by blocking mitophagy.
Topics: Adipocytes, Beige; Adiponectin; Adipose Tissue, White; Adiposity; Aging; Animals; Benzothiazoles; Cells, Cultured; Cold Temperature; Energy Metabolism; Insulin Resistance; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Mitophagy; Sirolimus; Toluene; Tumor Suppressor Protein p53 | 2019 |